Buprenorphine for pain relief in older adults with broken bones in the ED
Official title: Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department: a Randomized Controlled Study
Run by Cooper Norcross Health · NCT07430345 · Data updated 2026-11-12
This study tests whether buprenorphine can safely and effectively relieve pain in older adults with acute fractures, compared with hydromorphone.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Cooper Norcross Health Academic / other |
| Locations | 1 site (Camden, New Jersey) |
| Status | Recruiting |
| Started | May 7, 2026 |
| Main results expected | December 2026 |
| Study ends | January 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07430345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 65 years and older with an acute fracture presenting to the ED, able to consent or have a surrogate decision-maker.
✕Probably not a fit
Patients who do not experience adequate pain relief or who have adverse reactions to buprenorphine or hydromorphone may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study in older adults with suspected or confirmed acute fractures in the emergency department compares buprenorphine and hydromorphone for pain control over 48 hours. It is conducted in two phases (Phase 1 and Phase 2) to assess safety and efficacy in a geriatric population. Buprenorphine is a partial opioid with potential advantages in older patients, including fewer respiratory effects and no dose adjustments for liver or kidney issues. The trial will measure pain scores and adverse events after administration of the two drugs. Eligible participants are adults aged 65 and older seeking ED care for fracture who can consent or have a surrogate decision-maker.
Why it matters
Potential benefit: If successful, buprenorphine could provide effective pain relief with fewer side effects for older adults with fractures.
How similar studies have gone: Prior studies suggest buprenorphine can match or exceed efficacy of full agonists in acute pain, but older adults have been underrepresented.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 65 years or older * Emergency Department patient * Diagnosis of suspected or confirmed acute fracture * Numerical Rating Scale 4 or greater at time of presentation * Must be able to give informed consent or have a surrogate decisionmaker to provide informed consent * Subjects who may require a surgical procedure are eligible for enrollment, as given the low dose of buprenorphine, this is not anticipated to affect future anesthesia. If additional pain control is needed for surgical procedure, full agonist opioid can be used without contraindication. Exclusion Criteria: * Prior history of opioid use disorder * Participants taking chronic opioid therapy (defined as opioids taken during the past month) * Allergy to study medications * Hemodynamic instability requiring immediate resuscitation * Inability to consent and absence of surrogate decisionmaker
Where it's running
-
Cooper University Hospital
Camden, New Jersey, United States Recruiting
Study contacts
- Study coordinator: Katherine E Selman, MD
- Email: selman-katherine@cooperhealth.edu
- Phone: 856-342-2627
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
See how well iFuse TORQ TNT works for pelvic fragility fractures
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
-
Cannabidiol for pain relief after traumatic fractures and to reduce opioid use
We will test whether taking cannabidiol twice daily for one month can reduce pain and opioid use in adults 18–70 treated for recent long-bone fractures at Sacré-Coeur Hospital.
-
Observing outcomes of the Medacta Shoulder System
This study is looking at how well the Medacta Shoulder System works and its safety for people with different shoulder problems.
-
Comparing oral and intravenous antibiotics for treating infected nonunion of fractures
This study is testing whether taking antibiotics by mouth works as well as getting them through an IV for people with infected fractures that haven't healed properly after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.